Skip to main content
Clinical Trials/IRCT2015102524681N1
IRCT2015102524681N1
Completed
Phase 2

The comparison between Efficacy of Treatment With Propranolol in Newborns With Retinopathy of Prematurity and control

Vice chancellor for research, Guilan University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Retinopathy of prematurity.
Sponsor
Vice chancellor for research, Guilan University of Medical Sciences
Enrollment
50
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Guilan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Children with the diagnosis of retinopathy prematurity and lack of diseases such as any type of heart disease; low blood pressure; brain hemmorhage included in this study. Patients with severe complications of propranolol such as severe bradycardy or low blood pressure excluded.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials